Replacement - Director/PDMR Shareholding
Summary by AI BETAClose X
The following amendment has been made to the Director/PDMR Shareholding announcement released on 29 April 2026 at 13:23:26 under RNS #4417C:
The date of the vesting (28 April 2026) of Deferred Share Awards has been added to the introductory paragraph.
All other details remain unchanged.
The full amended text is shown below.
SAVILLS PLC (THE "COMPANY")
TRANSACTION IN SHARES BY DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)
Vesting of Deferred Share Awards
Awards over ordinary shares of the Company under the Company's Deferred Share Plans have become unconditional in all respects following the end of their Deferred Period. In satisfaction of the Awards, the Trustees of the Group's Employee Benefit Trusts have effected the transfer of shares on 28 April 2026, following the settlement of associated tax liabilities through the sale of shares, to Directors and PDMRs of the Company as follows:
|
Director/ PDMR |
Number of shares transferred |
Number of shares disposed to cover tax liabilities associated with award vesting |
Shareholding following this notification |
Shareholding as a % of issued share capital |
|
Simon Shaw (Director) |
48,468 |
43,468 (shares sold to cover tax liabilities associated with award vesting only) |
276,793 |
0.19% |
|
Martin Fidden (PDMR) |
8,664 |
- |
34,046 |
0.02% |
|
Alex Jeffrey (PDMR) |
53,143 |
- |
292,074 |
0.20% |
|
Chris Lee (PDMR) |
9,774 |
8,710 (shares sold to cover tax liabilities associated with award vesting only) |
133,311 |
0.09% |
|
Raymond Lee (PDMR) |
35,671 |
- |
211,852 |
0.14% |
|
David Lipson (PDMR) |
30,333 |
- |
175,760 |
0.12% |
|
James Sparrow (PDMR) |
42,767 |
38,106 (shares sold to cover tax liabilities associated with award vesting only) |
170,884 |
0.12% |
The share price on disposal of all shares was £8.405 per share.
Grant of Deferred Share Awards
The Company announces that on 28 April 2026 the grant of the share-based element of 2025 profit share awards has been made under The Savills Deferred Share Bonus Plan to Directors and PDMRs as follows:
|
Director/ PDMR |
Number of shares subject to The Savills Deferred Share Bonus Plan awarded to the Director/ PDMR on 28 April 2026 |
|
Simon Shaw (Director) |
111,077 |
|
Chris Lee (PDMR) |
22,155 |
|
David Lipson (PDMR) |
9,105 |
|
James Sparrow (PDMR) |
63,832 |
These awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased during the Deferred Period to reflect final and interim dividends declared during the Deferred Period.
The Company also announces that on 28 April 2026 the grant of an award has been made under The Savills Deferred Share Plan (No.2 Plan) to the following PDMR:
|
PDMR |
Number of shares subject to The Savills Deferred Share Plan (No.2 Plan) awarded to the PDMR on 28 April 2026 |
|
Martin Fidden (PDMR) |
119,758 |
13% of the above award has a Deferred Period of two years
51% of the above award has a Deferred Period of three years
36% of the above award has a Deferred Period of four years
70% of the award with a Deferred Period of three years and 100% of the award with a Deferred Period of four years is subject to the satisfaction of performance criteria relating to the financial performance of the Savills Asia Pacific ex-Greater China business over 2025 to 2027 (inclusive).
All tranches of the award are subject to rolled-up dividend shares whereby the number of shares awarded will be increased during the Deferred Periods to reflect final and interim dividends declared during the Deferred Periods.
The Company also announces that on 28 April 2026 the grant of an award has been made under The Schedule to The Savills Deferred Share Plan (No.2 Plan) to a PDMR based in the United States of America as follows:
|
PDMR |
Number of shares subject to the Savills Deferred Share Plan awarded to the PDMR on 28 April 2026 |
|
David Lipson (PDMR) |
44,214 |
One-third of Mr Lipson's award will vest on each of the three anniversaries subsequent to the date of grant subject to continued employment and performance. The award is subject to rolled-up dividend shares whereby the number of shares awarded will be increased during the Deferred Period to reflect final and interim dividends declared during the Deferred Periods.
Resulting beneficial interests under The Savills Deferred Share Bonus Plan and The Savills Deferred Share Plan (No.2 Plan) further to the above notifications are as follows:
|
Director/ PDMR |
Resulting beneficial interest under The Savills Deferred Share Bonus Plan and The Savills Deferred Share Plan (No.2 Plan) |
|
Simon Shaw (Director) |
237,302 |
|
Martin Fidden (PDMR) |
65,870 |
|
Alex Jeffrey (PDMR) |
75,287 |
|
Chris Lee (PDMR) |
48,348 |
|
David Lipson (PDMR) |
105,062 |
|
James Sparrow (PDMR) |
138,914 |
The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.
|
1. |
Details of the Director/ PDMR
|
||
|
(a) |
Name |
1. Simon Shaw 2. Martin Fidden 3. Alex Jeffrey 4. Chris Lee 5. Raymond Lee 6. David Lipson 7. James Sparrow
|
|
|
2. |
Reason for the notification
|
||
|
(a) |
Position/ status |
1. Group Chief Executive/ Director 2. Chief Executive Officer - Asia Pacific (ex-Greater China)/ PDMR 3. Chief Executive Officer - Savills Investment Management/ PDMR 4. Group Legal Director & Company Secretary/ PDMR 5. Chief Executive - Hong Kong, Macau and Greater China/ PDMR 6. Chief Executive Officer - Savills North America/ PDMR 7. Chief Executive Officer - UK & EMEA/ PDMR
|
|
|
(b) |
Initial notification/ Amendment
|
Initial notification |
|
|
3. |
Details of the issuer
|
||
|
(a) |
Name |
Savills plc
|
|
|
(b) |
LEI |
213800WXICGMBWHTA933
|
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||
|
(a) |
Description of the Financial Instrument
|
Savills plc Ordinary Shares of 2.5p each |
|
|
(b) |
Identification code of the Financial Instrument
|
GB00B135BJ46 |
|
|
(c) |
Nature of the transaction
|
1) Vesting of awards under the Company's Deferred Share Plans and sale of shares to cover tax liabilities associated with award vesting only 2) Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Plans
|
|
|
(d) |
Price(s) and volume(s)
|
Price(s) |
Volume(s)
|
|
1) Acquisition £nil per share
Disposal (to cover tax liabilities associated with award vesting only) £8.405 per share |
1. 92,253 2. 8,664 3. 53,143 4. 18,484 5. 35,671 6. 30,333 7. 80,873
1. 43,468 2. n/a 3. n/a 4. 8,710 5. n/a 6. n/a 7. 38,106
|
||
|
|
|
2) £nil per share |
1. 111,077 2. 119,758 3. n/a 4. 22,155 5. n/a 6. 53,316 7. 63,832
|
|
(e) |
Aggregated information
- Aggregated volume - Price
|
N/A
|
|
|
(f) |
Date of the transaction
|
28 April 2026 |
|
|
(g) |
Place of the transaction
|
Vesting of awards - Outside a trading venue
Sale of shares to cover tax liabilities associated with award vesting only - London Stock Exchange
Grant of awards - Outside a trading venue
|
|
Name of contact and telephone number for queries:
Chris Lee
Group Legal Director & Company Secretary
020 3107 5444
29 April 2026
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 9 hours ago Savannah Energy
- 10 hours ago Buccaneer Energy PLC
- 10 hours ago Savannah Energy
- 10 hours ago Carclo
- 11 hours ago Schroder Japan Growth Fund